Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETHOSUXIMIDE vs ETHYL LOFLAZEPATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ETHOSUXIMIDE vs ETHYL LOFLAZEPATE: Safety Overview

Metric ETHOSUXIMIDE ETHYL LOFLAZEPATE
Total FAERS Reports 1,249 215
Deaths Reported 10 16
Death Rate 0.8% 7.4%
Hospitalizations 260 98
Average Patient Age 18.9 yrs 51.5 yrs
% Female Patients 58.6% 39.7%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer PAI Holdings, LLC dba PAI Pharma N/A
Route ORAL N/A
Marketing Status Prescription N/A